India Supreme Court To Begin Hearings On Novartis Patent Rejection
This article was originally published in PharmAsia News
India's Supreme Court is set to begin hearing final arguments in a challenge to the nation's patent office by Novartis of Switzerland.
You may also be interested in...
Farah Ahmed, president and CEO of the Fragrance Creators Association, discusses the trade group’s expansion in recent years beyond immediate regulatory and legislative concerns to a platform for robust member collaboration in the name of positively impacting the world.
The amyloid-targeting drug is years behind Biogen/Eisai’s aducanumab, but its subcutaneous administration and the GRADUATE studies’ design could give Roche’s gantenerumab an advantage.